Antimycobacterials for Systemic use
Antimycobacterials for Systemic use Products (10)
-
Product Rifapentine + Isoniazid
Rifapentine combined with isoniazid (300 mg + 300 mg) is a prescription fixed-dose oral combination antibiotic used for the short-course treatment of latent tuberculosis infection (LTBI). It pairs a long-acting rifamycin derivative with a primary antimycobacterial agent to drastically shorten latent TB tre...
-
Product ANTIBIOTIC INJECTABLES AZTREONAM
API Strengths Available: 1 g & 2 g
Dosage Form: Sterile powder for injection (vial)
Packing Options: Glass vials with flip-off seals and tear-off aluminum caps, available in single vial mono, combi packs(WFI) or 10's vials pack
Customi...
-
Product Pyrazinamide
Pyrazinamide is a prescription oral antibiotic medication used exclusively in combination with other antituberculosis agents to treat active tuberculosis (TB) infections. It belongs to the primary class of anti-TB medications and plays a critical role in shortening the total duration of tuberculosis therapy
-
Product Rifampicin + Isoniazid
Rifampicin + Isoniazid Tablets 150 mg/150 mg are a fixed-dose combination (FDC) antitubercular medicine containing two first-line anti-tuberculosis agents: Rifampicin 150 mg and Isoniazid 150 mg. The combination is formulated to provide effective bactericidal activity against Mycobacterium tuberculosis whi...
-
Product ANTIBIOTIC INJECTABLES CEFEPIME
Cefepime for Injection with Sterile Water for Injection is a fourth-generation cephalosporin antibiotic with broad-spectrum activity. It inhibits bacterial cell wall synthesis and is used in the treatment of moderate to severe bacterial infections.
Pack Strengths Available: 1 g/vial (supplied ...
Upcoming Events
-
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026 -
CPHI & PMEC Shenzhen 2026
Shenzhen Convention & Exhibition Center (SZCEC), China
16 Sep 2026 - 18 Sep 2026